National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

SPS National Medicines Governance Do Once programme

The programme reduces duplication of effort and improves quality and consistency through national PGD templates and Medicines Policy and Governance principles
SPS national templates can be implemented by organisations to improve consistency and reduce duplication of effort.
The SPS National Medicines Governance Do Once programme produce national Patient Group Direction (PGD) exemplar templates for local adaptation

Scope of templates

The SPS national PGD, protocol and written-instruction templates are written in alignment with relevant national guidance to be applicable to a wide range of services, clinical environments and patient cohorts.

The templates are intended to support, not substitute, relevant national guidance and as such should always be used in practice alongside supporting guidance.

As the templates are intended to be used in a variety of different services and clinical environments, organisations may need to locally adapt the content to meet the needs of their local populations or service model, and other aspects such as laboratory reporting systems. For more information see Implementing the SPS Patient Group Direction, Written Instruction and protocol templates.

New or recently updated templates

PGD templates published or updated within the last 3 months (in date order, most recent at the top).

Ambulance

Created by SPS with the support of NASMeD and JRCALC.

Community Pharmacy

The NHS Pharmacy First Service PGDs/protocols can be found at:
Community Pharmacy advanced service specification: NHS Pharmacy First Service

Any queries regarding the NHS Pharmacy First Service PGDs/protocols should be directed to: ENGLAND.CommunityPharmacy@nhs.net

Infection and infectious diseases

Created by SPS with the support of specialist stakeholders including NICE, RCGP, ARPHAI, UKHSA and NHSE.

Central nervous system infections

Hepatitis C

Created by SPS with the support of specialist stakeholders working within clinical practice.
The hepatitis C PGDs have now been shared with the Operational Delivery Networks (ODNs) by the hepatitis C elimination team at NHS England.
Any queries regarding access to the hepatitis C PGDs should be directed to: ENGLAND.hepc-enquiries@nhs.net

Respiratory tract infections

Skin infections

Urinary tract infections

Pregnancy and supportive medicines

For use in antenatal and maternity services across all healthcare sectors.

Created by SPS and NHSE, with the support of specialist stakeholders working within clinical practice and the Royal College of Obstetrics and Gynaecology (RCOG), as part of the wider Preventative Medicines in Pregnancy programme.

Public Health

PGD templates are developed by UKHSA for a variety of clinical scenarios.

Note these PGDs are not developed by SPS; any queries regarding these templates should be directed to the UKHSA immunisation team at immunisation@ukhsa.gov.uk

Radiology

Created by SPS, NHS England, the Royal College of Radiologists (RCR) and the Society and College of Radiographers (SCoR), with the support of specialists working within NHS clinical practice. For use in radiology service in NHS England commissioned services.

Reproductive health and contraception

For use within reproductive health and contraception services across all healthcare sectors.

Created by SPS and the Faculty of Sexual and Reproductive Health (FSRH), with the support of specialist stakeholders working within clinical practice.

Sexual health

For use within sexual health services across all healthcare sectors.

Created by SPS and the British Association of Sexual Health and HIV (BASHH)/British Association of HIV (BHIVA), with the support of specialist stakeholders working within clinical practice.

Smoking cessation

Created by SPS with the support of specialist stakeholders including the National Centre for Smoking Cessation and Training (NCSCT), College of Mental Health Pharmacy (CMHP) and NHSE.

Templates in development

Treatment and prophylaxis of human and animal bites

Expected publication end of 2025:

  • Treatment and prophylaxis of human and animal bites: oral co-amoxiclav
  • Treatment and prophylaxis of human and animal bites: oral co-trimoxazole (penicillin allergy under 12 years of age)
  • Treatment and prophylaxis of human and animal bites: oral doxycycline and oral metronidazole (penicillin allergy 12 years of age and over)

Treatment of scabies

Expected publication end of 2025:

  • Topical permethrin for the treatment of scabies
  • Topical malathion for the treatment of scabies